Annual Accounts Payable
$1.08 M
+$1.05 M+3081.76%
31 December 2023
Summary:
Bellevue Life Sciences Acquisit annual accounts payable is currently $1.08 million, with the most recent change of +$1.05 million (+3081.76%) on 31 December 2023. During the last 3 years, it has risen by +$1.08 million (+38535.71%). BLACU annual accounts payable is now at all-time high.BLACU Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$1.26 M
+$206.90 K+19.66%
30 September 2024
Summary:
Bellevue Life Sciences Acquisit quarterly accounts payable is currently $1.26 million, with the most recent change of +$206.90 thousand (+19.66%) on 30 September 2024. Over the past year, it has increased by +$177.50 thousand (+16.41%). BLACU quarterly accounts payable is now -18.66% below its all-time high of $1.55 million, reached on 31 March 2024.BLACU Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLACU Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +16.4% |
| 3 y3 years | +10000.0% | +10000.0% |
| 5 y5 years | - | - |
BLACU Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -18.7% | >+9999.0% |
| 5 y | 5 years | at high | -18.7% | >+9999.0% | |
| alltime | all time | at high | -18.7% | >+9999.0% |
Bellevue Life Sciences Acquisit Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.26 M(+19.7%) |
| June 2024 | - | $1.05 M(-32.0%) |
| Mar 2024 | - | $1.55 M(+43.1%) |
| Dec 2023 | $1.08 M | $1.08 M(+116.2%) |
| Sept 2023 | - | $500.40 K(+87.8%) |
| June 2023 | - | $266.50 K(-31.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $386.40 K(+1036.5%) |
| Dec 2022 | $34.00 K(+1114.3%) | - |
| Dec 2022 | - | $34.00 K(+64.3%) |
| Sept 2022 | - | $20.70 K(+2487.5%) |
| June 2022 | - | $800.00(-71.4%) |
| Dec 2021 | $2800.00(>+9900.0%) | $2800.00 |
| Dec 2020 | $0.00 | - |
FAQ
- What is Bellevue Life Sciences Acquisit annual accounts payable?
- What is the all time high annual accounts payable for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bellevue Life Sciences Acquisit?
- What is Bellevue Life Sciences Acquisit quarterly accounts payable year-on-year change?
What is Bellevue Life Sciences Acquisit annual accounts payable?
The current annual accounts payable of BLACU is $1.08 M
What is the all time high annual accounts payable for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high annual accounts payable is $1.08 M
What is Bellevue Life Sciences Acquisit quarterly accounts payable?
The current quarterly accounts payable of BLACU is $1.26 M
What is the all time high quarterly accounts payable for Bellevue Life Sciences Acquisit?
Bellevue Life Sciences Acquisit all-time high quarterly accounts payable is $1.55 M
What is Bellevue Life Sciences Acquisit quarterly accounts payable year-on-year change?
Over the past year, BLACU quarterly accounts payable has changed by +$177.50 K (+16.41%)